Newsletter
Safety of Homeopathic Products
By Todd Hoover, M.D., DHT Safety of homeopathic medicines may be considered as part of the entire toxicology spectrum of any starting material. Let us take for example the commonly used homeopathic drug— Chamomilla.…
Read MoreSafety in Clinical Practice
By Dr. William Shevin, M.D., DABHM Homeopathic drug products (HDPs) are commonly thought to be extremely, if not absolutely, safe. Although HDPs have a very low risk profile based on…
Read MoreHow Safe Are Homeopathic Medicines; A Look at the Evidence
By Michelle L. Dossett, MD, PhD, MPH, FACP The safety of medicines is a key concern for patients, clinicians, and regulatory officials. Adverse effects of medications are common and can range…
Read MorePiecing Together Safety of Homeopathic Medicine: Researcher, Clinician, and Manufacturer Perspectives
By Mark Land, M.S., RAC-US, AAHP President In this issue we examine the safety of homeopathic medicines for the perspective of researchers, clinicians, and manufacturers. In general, evaluating the safety…
Read MoreFinished Testing of Homeopathic Products: A Retrospective Review of Thinking
By Mark Land, M.S., RAC-US, AAHP President In this issue we offer a series of evergreen of articles on finished product testing—a topic of constant focus. We chose to refresh…
Read MoreBreaking-News: FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
By Alissa Gould, Boiron USA On May 6, 2026, the U.S. Food and Drug Administration announced that it launched a one-day inspectional assessment pilot program. Essentially, instead of FDA relying…
Read MoreTribute to Sandra M. Chase, M.D., DABHM
By William Shevin, M.D., DABHM Dr. Chase joined the Homeopathic Pharmacopeia of the United States (HPCUS) in 1981 and retired on April 22, 2026 after serving for the last 40…
Read MoreSustaining the Standards That Support Our Industry
By Mark Land, M.S., RAC-US, AAHP President Many of the systems and standards that support homeopathy in the United States happens behind the scenes. Maintaining the HPUS requires ongoing work in areas like standards development, technical…
Read MoreGet Ready: FDA Revised the National Drug Code and Drug Label Barcode
In March 2026, the U.S. Food and Drug Administration (FDA) finalized its rule to standardize the format of the National Drug Code (NDC). Under this rule, FDA will move from…
Read MoreBuilding Resiliency and Improving the HPUS
By Todd A. Hoover, M.D., DABHM, Incoming President of HPCUS Board of Directors I am very pleased to be taking over the helm at the Homeopathic Pharmacopeia Convention of the…
Read More